These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 20524313)

  • 21. Proteasome inhibitor therapy for antibody-mediated rejection.
    Woodle ES; Walsh RC; Alloway RR; Girnita A; Brailey P
    Pediatr Transplant; 2011 Sep; 15(6):548-56. PubMed ID: 21884344
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The influence of bortezomib on donor specific antibody reduction in patients with antibody mediated rejection.
    Hardinger KL; Murillo D
    Clin Transpl; 2011; ():401-8. PubMed ID: 22755438
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lung transplantation across donor-specific anti-human leukocyte antigen antibodies: utility of bortezomib therapy in early graft dysfunction.
    Stuckey LJ; Kamoun M; Chan KM
    Ann Pharmacother; 2012 Jan; 46(1):e2. PubMed ID: 22202499
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bortezomib rescue in refractory acute humoral rejection--report of a case.
    Shapiro R; Basu A; Zeevi A; Lunz J; Mapara M; Randhawa P; Morgan C; Tan HP; Sharma V
    Clin Transpl; 2009; ():431-2. PubMed ID: 20524310
    [No Abstract]   [Full Text] [Related]  

  • 25. Bortezomib as a rescue therapy for hyperacute and multi-drug resistant mixed acute rejection after kidney transplantation.
    Djamali A; Muth BL; Torrealba J; Bloom D; Miller KM; Lorentzen D; Sollinger HW; Pirsch JD; Mezrich JD
    Clin Transpl; 2009; ():485-90. PubMed ID: 20524320
    [No Abstract]   [Full Text] [Related]  

  • 26. Proteasome inhibition with bortezomib: an effective therapy for severe antibody mediated rejection after renal transplantation.
    Sureshkumar KK; Hussain SM; Marcus RJ; Ko TY; Khan AS; Tom K; Vivas CA; Parris G; Jasnosz KM; Thai NL
    Clin Nephrol; 2012 Mar; 77(3):246-53. PubMed ID: 22377258
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A summary of bortezomib use in transplantation across 29 centers.
    Everly MJ
    Clin Transpl; 2009; ():323-37. PubMed ID: 20524294
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The state of therapy for removal of alloantibody producing plasma cells in transplantation.
    Everly MJ; Terasaki PI
    Semin Immunol; 2012 Apr; 24(2):143-7. PubMed ID: 22153981
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bortezomib for antibody mediated rejection treatment: experience at the Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán in Mexico City.
    Leyva S; Marino-Vázquez LA; Reyes-Loaeza JA; Vega O; Uribe-Uribe N; Alberú J; Morales-Buenrostro LE
    Clin Transpl; 2009; ():369-76. PubMed ID: 20524300
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High immunologic risk living donor kidney transplant using bortezomib in a novel induction regimen without acute antibody mediated rejection.
    Dunn TB; Borja-Cacho D; Chinnakotla S; Finger E; Tamayo G; Verghese P; Kim Y; Manivel C; Kandaswamy R; Matas A; Pruett T; Noreen H; Krefting P; Maurer D
    Clin Transpl; 2011; ():381-7. PubMed ID: 22755435
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Successful desensitization in a crossmatch positive living-related kidney transplant recipient using a bortezomib-based protocol.
    Zhu L; Lin Z; Xiang Y; Liu S; Chen G
    Clin Transpl; 2009; ():359-60. PubMed ID: 20524298
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bortezomib as therapy for mixed humoral and cellular rejection: should it be first line?
    Lee I; Constantinescu S; Gillespie A; Swami A; Birkenbach M; Leech S; Silva P; Karachristos A; Daller JA; Sifontis NM
    Clin Transpl; 2009; ():425-9. PubMed ID: 20524309
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparison between bortezomib and rituximab in the treatment of antibody-mediated renal allograft rejection.
    Waiser J; Budde K; Schütz M; Liefeldt L; Rudolph B; Schönemann C; Neumayer HH; Lachmann N
    Nephrol Dial Transplant; 2012 Mar; 27(3):1246-51. PubMed ID: 21852274
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bortezomib as rescue therapy for antibody mediated rejection: a single-center experience.
    Hardinger KL; Alford K; Murillo D
    Clin Transpl; 2010; ():429-36. PubMed ID: 21696060
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effective therapy for acute antibody-mediated rejection with mild chronic changes: case report and review of the literature.
    Gheith O; Al-Otaibi T; Nampoory N; Halim M; Nair P; Saied T; Al-Waheeb S; Muzeirei I; Ibraheim M
    Exp Clin Transplant; 2012 Aug; 10(4):406-9. PubMed ID: 22746156
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The fate of anti-HLA antibody among renal transplantation recipients treated with bortezomib.
    Lonze BE; Dagher NN; Simpkins CE; Singer AL; Segev DL; Zachary AA; Montgomery RA
    Clin Transpl; 2009; ():377-84. PubMed ID: 20524301
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bortezomib for the treatment of chronic antibody-mediated kidney allograft rejection: a case report.
    Schwaiger E; Regele H; Wahrmann M; Werzowa J; Haidbauer B; Schmidt A; Böhmig GA
    Clin Transpl; 2010; ():391-6. PubMed ID: 21696056
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of the proteasome inhibitor bortezomib on humoral immunity in two presensitized renal transplant candidates.
    Wahrmann M; Haidinger M; Körmöczi GF; Weichhart T; Säemann MD; Geyeregger R; Kikić Z; Prikoszovich T; Drach J; Böhmig GA
    Transplantation; 2010 Jun; 89(11):1385-90. PubMed ID: 20335829
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bortezomib for the treatment of de novo HLA antibody-related antibody mediated rejection.
    Al Meshari K
    Clin Transpl; 2009; ():385-6. PubMed ID: 20524302
    [No Abstract]   [Full Text] [Related]  

  • 40. Antibody-mediated rejection in kidney transplantation: an update.
    Lucas JG; Co JP; Nwaogwugwu UT; Dosani I; Sureshkumar KK
    Expert Opin Pharmacother; 2011 Mar; 12(4):579-92. PubMed ID: 21294653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.